Location: Greenwich, CT
CIK: 0001281446 · Show all filings
Period: Q2 2026 (← Previous)
Filing Date: Aug 14, 2026
Total Value: $529M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ABVX | ABIVAX SA | 400,000 | $53.3M | 10.1% | — | — | Call | 00370M103 |
| VOR | VOR BIOPHARMA INC | 1,700,000 | $31.3M | 5.9% | — | — | COM NEW | 929033207 |
| ABVX | ABIVAX SA | 204,314 | $27.23M | 5.1% | — | — | SPONSORED ADS | 00370M103 |
| IBRX | IMMUNITYBIO INC | 3,000,800 | $26.27M | 5.0% | — | — | Put | 45256X103 |
| VERA | VERA THERAPEUTICS INC | 600,836 | $25.78M | 4.9% | — | — | CL A | 92337R101 |
| ZURA | ZURA BIO LTD | 4,215,930 | $24.87M | 4.7% | — | — | CLASS A ORD SHS | G9TY5A101 |
| ALMS | ALUMIS INC | 856,061 | $24.09M | 4.6% | — | — | COM | 022307102 |
| SLGL | SOL-GEL TECHNOLOGIES LTD | 274,363 | $20.34M | 3.8% | — | — | SHS NEW | M8694L137 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 600,000 | $20.03M | 3.8% | — | — | Put | 90400D108 |
| DFTX | DEFINIUM THERAPEUTICS INC | 425,000 | $19.99M | 3.8% | — | — | COM SHS | 24477V105 |
| ANNX | ANNEXON INC | 3,500,000 | $19.98M | 3.8% | — | — | COM | 03589W102 |
| ORKA | ORUKA THERAPEUTICS INC | 183,330 | $17.45M | 3.3% | — | — | COM | 687604108 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 855,813 | $16.66M | 3.1% | — | — | CLASS A ORD | 61559X104 |
| SGMT | SAGIMET BIOSCIENCES INC | 2,029,933 | $15.69M | 3.0% | — | — | COM SER A | 786700104 |
| CTNM | CONTINEUM THERAPEUTICS INC | 921,481 | $15.1M | 2.9% | — | — | CL A | 21217B100 |
| IMMX | IMMIX BIOPHARMA INC | 1,277,642 | $13.17M | 2.5% | — | — | COM | 45258H106 |
| CLYM | CLIMB BIO INC | 1,000,000 | $13.04M | 2.5% | — | — | COM | 28658R106 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 700,000 | $12.57M | 2.4% | — | — | COM | 03237H101 |
| NKTR | NEKTAR THERAPEUTICS | 175,000 | $12.22M | 2.3% | — | — | COM NEW | 640268306 |
| NGNE | NEUROGENE INC | 352,180 | $11.08M | 2.1% | — | — | COM | 64135M105 |
| LBRX | LB PHARMACEUTICALS INC | 317,221 | $10.3M | 1.9% | — | — | COM SHS | 50180M108 |
| IRD | OPUS GENETICS INC | 1,970,187 | $8.097M | 1.5% | — | — | COM | 67577R102 |
| EPRX | EUPRAXIA PHARMACEUTICALS INC | 1,200,000 | $7.932M | 1.5% | — | — | COM | 29842P105 |
| DRUG | BRIGHT MINDS BIOSCIENCES INC | 109,603 | $7.694M | 1.5% | — | — | COM NEW | 10919W405 |
| IFRX | INFLARX NV | 3,046,557 | $6.824M | 1.3% | — | — | COM | N44821101 |
| RLMD | RELMADA THERAPEUTICS INC | 842,106 | $5.827M | 1.1% | — | — | COM | 75955J402 |
| JATT | JATT II ACQUISITION CORP | 500,000 | $5.68M | 1.1% | — | — | ORD SHS | G50765109 |
| CGEM | CULLINAN THERAPEUTICS INC | 300,000 | $5.463M | 1.0% | — | — | COM | 230031106 |
| ALT | ALTIMMUNE INC | 1,741,232 | $5.293M | 1.0% | — | — | COM NEW | 02155H200 |
| AMAN | AMANAT ACQUISITION CORP | 500,000 | $5.08M | 1.0% | — | — | CL A ORD | G0375M101 |
| RZLT | REZOLUTE INC | 951,809 | $4.949M | 0.9% | — | — | COM NEW | 76200L309 |
| SLN | SILENCE THERAPEUTICS PLC | 450,000 | $4.941M | 0.9% | — | — | ADS | 82686Q101 |
| PALI | PALISADE BIO INC | 2,284,819 | $4.775M | 0.9% | — | — | COM | 696389402 |
| EVMN | EVOMMUNE INC | 325,000 | $4.319M | 0.8% | — | — | COM SHS | 30054Y107 |
| SCYX | SCYNEXIS INC | 944,292 | $3.843M | 0.7% | — | — | COM | 811292309 |
| GALT | GALECTIN THERAPEUTICS INC | 800,000 | $3.712M | 0.7% | — | — | Call | 363225202 |
| ELVN | ENLIVEN THERAPEUTICS INC | 70,000 | $3.553M | 0.7% | — | — | COM | 29337E102 |
| HUMA | HUMACYTE INC | 3,750,000 | $2.926M | 0.6% | — | — | COM | 44486Q103 |
| RNTX | REIN THERAPEUTICS INC | 2,575,000 | $2.678M | 0.5% | — | — | COM NEW | 00887A204 |
| DBVT | DBV TECHNOLOGIES S A | 156,906 | $2.573M | 0.5% | — | — | SPONSORED ADS | 23306J309 |
| AVXL | ANAVEX LIFE SCIENCES CORP | 521,300 | $1.35M | 0.3% | — | — | Call | 032797300 |
| PMN | PROMIS NEUROSCIENCES INC | 86,150 | $1.134M | 0.2% | — | — | COM SHS | 74346M505 |